CHICAGO—A woman whose death in a gene therapy study shut it down and prompted a review of the safety of 28 other studies was experiencing multiple organ failure when she got to the hospital, a spokesman said.Jolee Mohr, 36, died July 24, 22 days after receiving her second injection of an experimental drug made of genetically engineered viruses she hoped would help her arthritis.
